Displaying drugs 6576 - 6600 of 8235 in total
MRX-I
MRX-I has been used in trials studying the treatment of Bacterial Infections.
Investigational
Matched Description: … MRX-I has been used in trials studying the treatment of Bacterial Infections. …
XL-888
XL888 has been used in trials studying the treatment of Cancer and Melanoma.
Investigational
Matched Description: … XL888 has been used in trials studying the treatment of Cancer and Melanoma. …
LY-518674
LY518674 has been used in trials studying the treatment of Metabolic Syndrome X.
Investigational
Matched Description: … LY518674 has been used in trials studying the treatment of Metabolic Syndrome X. …
MK-6186
MK6186 has been used in trials studying the treatment of HIV-1 Infection.
Investigational
Matched Description: … MK6186 has been used in trials studying the treatment of HIV-1 Infection. …
IPI-493
IPI-493 has been used in trials studying the treatment of Advanced Malignancies.
Investigational
Matched Description: … IPI-493 has been used in trials studying the treatment of Advanced Malignancies. …
Ornidazole
Ornidazole has been used in trials studying the prevention of Elective Colorectal Surgery.
Investigational
Matched Description: … Ornidazole has been used in trials studying the prevention of Elective Colorectal Surgery. …
MK-0873
MK-0873 has been used in trials studying the treatment of Rheumatoid Arthritis.
Investigational
Matched Description: … MK-0873 has been used in trials studying the treatment of Rheumatoid Arthritis. …
Niobium
Niobium has been used in trials studying the treatment of Obesity and Overweight.
Investigational
Matched Description: … Niobium has been used in trials studying the treatment of Obesity and Overweight. …
CP-195543
CP-195,543 has been used in trials studying the treatment of Arthritis, Rheumatoid.
Investigational
Matched Description: … CP-195,543 has been used in trials studying the treatment of Arthritis, Rheumatoid. …
PF-03814735
PF-03814735 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Description: … PF-03814735 has been used in trials studying the treatment of Solid Tumors. …
CEP-37440
CEP-37440 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Description: … CEP-37440 has been used in trials studying the treatment of Solid Tumors. …
ME-344
ME-344 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Description: … ME-344 has been used in trials studying the treatment of Solid Tumors. …
AZD-0424
AZD0424 has been used in trials studying the treatment of Advanced Solid Tumours.
Investigational
Matched Description: … AZD0424 has been used in trials studying the treatment of Advanced Solid Tumours. …
CT-2584
CT-2584 has been used in trials studying the treatment of Prostate Cancer.
Investigational
Matched Description: … CT-2584 has been used in trials studying the treatment of Prostate Cancer. …
Hydroxypropyl tetrahydropyrantriol
Hydroxypropyl tetrahydropyrantriol has been used in trials studying the basic science of Aging.
Investigational
Matched Description: … Hydroxypropyl tetrahydropyrantriol has been used in trials studying the basic science of Aging. …
Troxerutin
Troxerutin has been used in trials studying the treatment of Chronic Venous Insufficiency.
Investigational
Matched Description: … Troxerutin has been used in trials studying the treatment of Chronic Venous Insufficiency. …
AGN-201904
Agn 201904 has been used in trials studying the prevention of Peptic Ulcer.
Investigational
Matched Description: … Agn 201904 has been used in trials studying the prevention of Peptic Ulcer. …
JQ1
First-in-class potent and selective inhibitor of the BRD4 signaling pathway.
Investigational
Matched Description: … First-in-class potent and selective inhibitor of the BRD4 signaling pathway.[A252967] …
ASP-7317
ASP-7317 consists of human embryonic stem cell-derived retinal pigment epithelium cells.
Investigational
Matched Description: … ASP-7317 consists of human embryonic stem cell-derived retinal pigment epithelium cells. …
CLZ-2002
CLZ-2002 consists of allogeneic mesenchymal stem cells derived neuronal regeneration-promoting cells.
Investigational
Matched Description: … CLZ-2002 consists of allogeneic mesenchymal stem cells derived neuronal regeneration-promoting cells. …
Chlorhexadol
Chlorhexadol is a sedative and hypnotic which is regulated in the United States as a Schedule III controlled substance. It is a derivative of chloral hydrate.
Experimental
Illicit
Matched Description: … It is a derivative of chloral hydrate. …
1,4-Dithiothreitol
A reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of SH (thiol) groups and for reducing disulphides to dithiols. [PubChem]
Experimental
Matched Description: … A reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of SH ( …
DAS-431 IV
DAS-431 IV is a dopamine D1 receptor agonist developed by DrugAbuse Sciences for the treatment of Addictions, Schizophrenia, Schizoaffective Disorders, Dementia, Parkinson's Disease, Strokes etc.
Investigational
Matched Description: … DAS-431 IV is a dopamine D1 receptor agonist developed by DrugAbuse Sciences for the treatment of Addictions …
Mirdametinib
PD-0325901 has been used in trials studying the treatment and basic science of Melanoma, Solid Tumour, Solid Tumors, Advanced Cancer, and Breast Neoplasms, among others.
Investigational
Matched Description: … PD-0325901 has been used in trials studying the treatment and basic science of Melanoma, Solid Tumour …
Eprenetapopt
Eprenetapopt has been used in trials studying the treatment of Prostatic Neoplasms, Hematologic Neoplasms, and Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53.
Investigational
Matched Description: … Eprenetapopt has been used in trials studying the treatment of Prostatic Neoplasms, Hematologic Neoplasms …
Displaying drugs 6576 - 6600 of 8235 in total